JP2020526202A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2020526202A5 JP2020526202A5 JP2020500687A JP2020500687A JP2020526202A5 JP 2020526202 A5 JP2020526202 A5 JP 2020526202A5 JP 2020500687 A JP2020500687 A JP 2020500687A JP 2020500687 A JP2020500687 A JP 2020500687A JP 2020526202 A5 JP2020526202 A5 JP 2020526202A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- nucleotide sequence
- amino acid
- acid sequence
- amino acids
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2021175480A JP2022031653A (ja) | 2017-07-11 | 2021-10-27 | Ｃｅａ、ｍｕｃ１およびｔｅｒｔを含む免疫原性組成物 |
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762531227P | 2017-07-11 | 2017-07-11 | |
| US62/531,227 | 2017-07-11 | ||
| US201862682044P | 2018-06-07 | 2018-06-07 | |
| US62/682,044 | 2018-06-07 | ||
| PCT/IB2018/054926 WO2019012371A1 (en) | 2017-07-11 | 2018-07-03 | IMMUNOGENIC COMPOSITIONS COMPRISING CEA MUC1 AND TERT |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021175480A Division JP2022031653A (ja) | 2017-07-11 | 2021-10-27 | Ｃｅａ、ｍｕｃ１およびｔｅｒｔを含む免疫原性組成物 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2020526202A JP2020526202A (ja) | 2020-08-31 |
| JP2020526202A5 true JP2020526202A5 (enExample) | 2021-03-25 |
| JP7028953B2 JP7028953B2 (ja) | 2022-03-02 |
Family
ID=63720720
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020500687A Expired - Fee Related JP7028953B2 (ja) | 2017-07-11 | 2018-07-03 | Ｃｅａ、ｍｕｃ１およびｔｅｒｔを含む免疫原性組成物 |
| JP2021175480A Pending JP2022031653A (ja) | 2017-07-11 | 2021-10-27 | Ｃｅａ、ｍｕｃ１およびｔｅｒｔを含む免疫原性組成物 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021175480A Pending JP2022031653A (ja) | 2017-07-11 | 2021-10-27 | Ｃｅａ、ｍｕｃ１およびｔｅｒｔを含む免疫原性組成物 |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US20190016775A1 (enExample) |
| EP (1) | EP3651792A1 (enExample) |
| JP (2) | JP7028953B2 (enExample) |
| KR (1) | KR20200027551A (enExample) |
| CN (1) | CN111065408A (enExample) |
| AU (1) | AU2018300295A1 (enExample) |
| BR (1) | BR112020000413A2 (enExample) |
| CA (1) | CA3069363A1 (enExample) |
| CO (1) | CO2020000231A2 (enExample) |
| IL (1) | IL271917A (enExample) |
| PE (1) | PE20200613A1 (enExample) |
| PH (1) | PH12020500087A1 (enExample) |
| RU (1) | RU2020100072A (enExample) |
| SG (1) | SG11202000197PA (enExample) |
| TW (1) | TW201920674A (enExample) |
| WO (1) | WO2019012371A1 (enExample) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE102020201219A1 (de) | 2020-01-31 | 2021-08-05 | United Initiators Gmbh | Transport- und Lagerbehälter für Peroxide |
| CN112552380B (zh) * | 2020-12-10 | 2021-12-24 | 武汉博沃生物科技有限公司 | 一种SARS-CoV-2病毒的免疫原及其应用 |
Family Cites Families (30)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4603112A (en) | 1981-12-24 | 1986-07-29 | Health Research, Incorporated | Modified vaccinia virus |
| US4769330A (en) | 1981-12-24 | 1988-09-06 | Health Research, Incorporated | Modified vaccinia virus and methods for making and using the same |
| US5288641A (en) | 1984-06-04 | 1994-02-22 | Arch Development Corporation | Herpes Simplex virus as a vector |
| CA1341423C (en) | 1984-10-31 | 2003-03-04 | Paul A. Luciw | Recombinant proteins of viruses associated with lymphadenopathy syndrome and/or acquired immune deficiency syndrome |
| GB8508845D0 (en) | 1985-04-04 | 1985-05-09 | Hoffmann La Roche | Vaccinia dna |
| US5091309A (en) | 1986-01-16 | 1992-02-25 | Washington University | Sindbis virus vectors |
| WO1989001973A2 (en) | 1987-09-02 | 1989-03-09 | Applied Biotechnology, Inc. | Recombinant pox virus for immunization against tumor-associated antigens |
| US5591624A (en) | 1988-03-21 | 1997-01-07 | Chiron Viagene, Inc. | Retroviral packaging cell lines |
| US5716826A (en) | 1988-03-21 | 1998-02-10 | Chiron Viagene, Inc. | Recombinant retroviruses |
| US5703055A (en) | 1989-03-21 | 1997-12-30 | Wisconsin Alumni Research Foundation | Generation of antibodies through lipid mediated DNA delivery |
| US5817491A (en) | 1990-09-21 | 1998-10-06 | The Regents Of The University Of California | VSV G pseusdotyped retroviral vectors |
| US6015686A (en) | 1993-09-15 | 2000-01-18 | Chiron Viagene, Inc. | Eukaryotic layered vector initiation systems |
| US6962790B1 (en) | 1998-09-23 | 2005-11-08 | University Of Massachusetts Medical Center | Predictive assay for immune response |
| EE05627B1 (et) | 1998-12-23 | 2013-02-15 | Pfizer Inc. | CTLA-4 vastased inimese monoklonaalsed antikehad |
| EP1212422B1 (en) | 1999-08-24 | 2007-02-21 | Medarex, Inc. | Human ctla-4 antibodies and their uses |
| TWI228718B (en) | 2001-11-05 | 2005-03-01 | Tdk Corp | Manufacturing method and device of mold plate for information medium |
| DE10162480A1 (de) * | 2001-12-19 | 2003-08-07 | Ingmar Hoerr | Die Applikation von mRNA für den Einsatz als Therapeutikum gegen Tumorerkrankungen |
| EP2163260B1 (en) | 2004-01-23 | 2017-03-15 | MSD Italia S.r.l. | Chimpanzee adenovirus vaccine carriers |
| AU2007306368B2 (en) * | 2006-10-12 | 2012-05-03 | Istituto Di Ricerche Di Biologia Molecolare P. Angeletti Spa | Telomerase reverse transcriptase fusion protein, nucleotides encoding it, and uses thereof |
| RS57132B1 (sr) | 2008-07-08 | 2018-07-31 | Incyte Holdings Corp | 1,2,5-oksadiazoli kao inhibitori indolamin 2,3-dioksigenaze |
| EP3385387B1 (en) | 2009-02-02 | 2021-08-25 | GlaxoSmithKline Biologicals SA | Simian adenovirus nucleic acid- and amino acid-sequences, vectors containing same, and uses thereof |
| US9128725B2 (en) | 2012-05-04 | 2015-09-08 | Apple Inc. | Load-store dependency predictor content management |
| UA120247C2 (uk) * | 2012-11-20 | 2019-11-11 | Санофі | Антитіло до ceacam5 і його застосування |
| JP2014161283A (ja) * | 2013-02-26 | 2014-09-08 | Shizuoka Prefecture | Ｃｅａｃａｍ５遺伝子のスプライシングバリアント |
| KR20160042935A (ko) * | 2013-08-21 | 2016-04-20 | 큐어백 아게 | 폐암 치료를 위한 조성물 및 백신 |
| MX2016005576A (es) | 2013-10-28 | 2016-12-09 | Piramal Entpr Ltd | Composicion herbaria, procedimiento para su preparacion y uso de la misma. |
| MY196581A (en) | 2013-11-01 | 2023-04-19 | Pfizer | Vectors for Expression of Prostate-Associated Antigens |
| CN106536480B (zh) | 2014-05-15 | 2019-09-03 | 艾特奥斯治疗公司 | 吡咯烷-2,5-二酮衍生物、药物组合物及用作ido1抑制剂的方法 |
| TWI595006B (zh) | 2014-12-09 | 2017-08-11 | 禮納特神經系統科學公司 | 抗ｐｄ－１抗體類和使用彼等之方法 |
| JP6647315B2 (ja) * | 2015-01-09 | 2020-02-14 | イーチュービクス コーポレイション | 組み合わせ免疫療法のための方法および組成物 |
-
2018
- 2018-07-03 KR KR1020207003864A patent/KR20200027551A/ko not_active Ceased
- 2018-07-03 AU AU2018300295A patent/AU2018300295A1/en not_active Abandoned
- 2018-07-03 RU RU2020100072A patent/RU2020100072A/ru unknown
- 2018-07-03 SG SG11202000197PA patent/SG11202000197PA/en unknown
- 2018-07-03 CA CA3069363A patent/CA3069363A1/en not_active Abandoned
- 2018-07-03 WO PCT/IB2018/054926 patent/WO2019012371A1/en not_active Ceased
- 2018-07-03 PE PE2020000050A patent/PE20200613A1/es unknown
- 2018-07-03 JP JP2020500687A patent/JP7028953B2/ja not_active Expired - Fee Related
- 2018-07-03 BR BR112020000413-8A patent/BR112020000413A2/pt not_active Application Discontinuation
- 2018-07-03 EP EP18780215.2A patent/EP3651792A1/en not_active Withdrawn
- 2018-07-03 CN CN201880057887.4A patent/CN111065408A/zh active Pending
- 2018-07-06 TW TW107123509A patent/TW201920674A/zh unknown
- 2018-07-09 US US16/029,878 patent/US20190016775A1/en not_active Abandoned
-
2020
- 2020-01-08 IL IL271917A patent/IL271917A/en unknown
- 2020-01-10 PH PH12020500087A patent/PH12020500087A1/en unknown
- 2020-01-10 CO CONC2020/0000231A patent/CO2020000231A2/es unknown
-
2021
- 2021-10-27 JP JP2021175480A patent/JP2022031653A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP3995712B2 (ja) | 生の組換え細菌ワクチンベクターを用いる癌の特異的免疫療法 | |
| JP2022160401A5 (enExample) | ||
| TWI676636B (zh) | 包含ｐｄ－１抗原或ｐｄ－１配體抗原的類病毒粒子 | |
| JP2018509936A5 (enExample) | ||
| JP2016505635A5 (enExample) | ||
| JP2017513502A5 (enExample) | ||
| JP2019536426A5 (enExample) | ||
| CN113056477A (zh) | 用于在疾病的预防和/或治疗中使用的疫苗 | |
| CN114592010A (zh) | NK-CAR-MbIL-15细胞及其制备方法和应用 | |
| JP6406647B2 (ja) | 細胞性免疫誘導ワクチン | |
| JP2019517790A5 (enExample) | ||
| JP4033497B2 (ja) | ワクチン製剤 | |
| CN111154806A (zh) | 一种嵌合外源超级细胞因子的溶瘤病毒载体系统及其在药物中的应用 | |
| JP6293882B2 (ja) | 遺伝的に安定な腫瘍溶解性ｒｎａウイルス、その製造方法およびその使用 | |
| JP2014139185A5 (enExample) | ||
| JP2020526202A5 (enExample) | ||
| WO2017120997A1 (zh) | 共表达抗EGFRvIII嵌合抗原受体和无功能EGFR的转基因淋巴细胞及其用途 | |
| JP2019505210A5 (enExample) | ||
| RU2018126487A (ru) | Противораковые вакцины | |
| RU2020100072A (ru) | Иммуногенные композиции, содержащие cea, muc1 и tert | |
| CN106177947A (zh) | 免疫监测点阻断药物和肿瘤疫苗联合的制药用途 | |
| CN109790224A (zh) | Cacna1h衍生的肿瘤抗原多肽及其应用 | |
| RU2011120447A (ru) | Эпитопные пептиды rab6kifl/kif20a и содержащие их вакцины | |
| US20240325510A1 (en) | Novel anti-cancer vaccine composition and a method of vaccination using the same | |
| CN102898508B (zh) | 封闭TGF-β受体或IL-10受体的多肽、其药物组合物及其用途 |